- Home
- JMIA vs BLFS Comparison
JMIA vs BLFS Comparison
Compare JMIA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JMIA | BLFS |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 862.0M | 923.5M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | JMIA | BLFS |
|---|---|---|
| Price | $7.07 | $20.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $16.75 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 3.1M | 328.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $22.18 | $19.73 |
| Revenue Next Year | $23.26 | $17.82 |
| P/E Ratio | ★ N/A | $1,049.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $2.89 | $17.86 |
| 52 Week High | $14.72 | $29.57 |
Technical Indicators
Market Signals| Indicator | JMIA | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 43.77 |
| Support Level | $6.70 | $19.71 |
| Resistance Level | $9.49 | $20.47 |
| Average True Range (ATR) | 0.50 | 0.95 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 14.50 | 17.85 |
Price Performance
Historical ComparisonAbout JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.